logo

Avalo Therapeutics Inc (AVTX) Stock: Navigating a Year of Stock Volatility

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Avalo Therapeutics Inc’s current trading price is -98.42% away from its 52-week high, while its distance from the 52-week low is 353.15%. The stock’s price range over this period has fluctuated between $3.95 and $1130.40. The company, operating within the financial sector, had a trading volume of approximately 1.97 million for the day, which was noticeably higher than the average daily share volume of 0.61 million over the last 3 months.

Avalo Therapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $1130.40 on 06/23/23 and the lowest value was $3.95 on 01/17/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Avalo Therapeutics Inc (AVTX) has experienced a quarterly rise of 51.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 14.32M and boasts a workforce of 19 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 9.99, with a change in price of -6.89. Similarly, Avalo Therapeutics Inc recorded 446,042 in trading volume during the last 100 days, posting a change of -27.80%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for AVTX stands at 0.53. Similarly, the long-term debt-to-equity ratio is also 0.46.

AVTX Stock Stochastic Average

Today, Avalo Therapeutics Inc’s raw stochastic average for the past 50 days stands at 45.62%, indicating a rise from the raw stochastic average of the last 20 days, which was 45.00%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 53.57% and 44.60% respectively.

AVTX Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 96.70% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -47.25%. Over the past 30 days, the price of AVTX has fallen by 305.90%. And in the last five days, it has surged by 266.80%.